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Abstract 
Background: Low birthweight has been repeatedly associated with long-term adverse health outcomes and many 
non-communicable diseases. Our aim was to look-up cord blood birthweight-associated CpG sites identified by the 
PACE Consortium in infant saliva, and to explore saliva-specific DNA methylation signatures of birthweight.
Methods: DNA methylation was assessed using Infinium HumanMethylation450K array in 135 saliva samples col-
lected from children of the NINFEA birth cohort at an average age of 10.8 (range 7–17) months. The association 
analyses between birthweight and DNA methylation variations were carried out using robust linear regression models 
both in the exploratory EWAS analyses and in the look-up of the PACE findings in infant saliva.
Results: None of the cord blood birthweight-associated CpGs identified by the PACE Consortium was associated 
with birthweight when analysed in infant saliva. In saliva EWAS analyses, considering a false discovery rate p-val-
ues < 0.05, birthweight as continuous variable was associated with DNA methylation in 44 CpG sites; being born small 
for gestational age (SGA, lower  10th percentile of birthweight for gestational age according to WHO reference charts) 
was associated with DNA methylation in 44 CpGs, with only one overlapping CpG between the two analyses. Despite 
no overlap with PACE results at the CpG level, two of the top saliva birthweight CpGs mapped at genes associated 
with birthweight with the same direction of the effect also in the PACE Consortium (MACROD1 and RPTOR).
Conclusion: Our study provides an indication of the birthweight and SGA epigenetic salivary signatures in children 
around 10 months of age. DNA methylation signatures in cord blood may not be comparable with saliva DNA meth-
ylation signatures at about 10 months of age, suggesting that the birthweight epigenetic marks are likely time and 
tissue specific.
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Background
The existence of a relationship between intrauterine or 
early life exposures and health during the lifecourse has 
come to attention in the 1990s [1] and is nowadays recog-
nized as the developmental origins of health and diseases 
(DOHAD) hypothesis [2]. The intrauterine life is a criti-
cal period for adverse exposures to exert their effect [3], 
as fetal organs start developing and are sensitive to envi-
ronmental stimuli that may cause an indelible imprint on 
future development and function.
In a hostile uterine environment caused by insults, 
for example poor nutrition, the fetus, to slow down 
its growth rate in order to match the nutrient supply, 
responds by developing adaptations including down-
regulation of metabolic or organs function. The adaptive 
process, however, may cause irreversible changes in the 
development of some tissues and organs and predispose 
an individual to a higher risk of diseases not only early in 
life, but during the entire lifecourse [2].
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Low birthweight may be associated with accumulation 
of adipose tissue and rapid weight gain during childhood 
[3], and the risk of respiratory [4, 5], metabolic [6, 7] and 
cardiovascular diseases [8, 9], hypertension [10], and 
neurobehavioral disorders [11]. Low birthweight has also 
been associated with an increased overall mortality [12], 
while cancer incidence rises with increasing birthweight 
for most types of cancer [13–17].
The Pregnancy and Childhood Epigenetics (PACE) 
Consortium conducted so far the largest cord blood 
epigenome-wide DNA methylation study of birthweight 
using 8825 neonatal blood samples from 24 birth cohorts 
[18] and found that 914 CpGs, located in or near 729 
genes, were associated with birthweight treated as a con-
tinuous variable. In the same study, methylation variation 
in 51 CpG sites was associated with high birthweight, as 
compared to normal birthweight, and 4 CpGs appeared 
to be associated with low versus normal birthweight. 
In additional analyses conducted on blood from 7278 
children at later ages, only 1.3% of the 914 birthweight-
associated differentially methylated CpGs in cord blood 
remained associated in childhood (2–13  years; n = 2756 
children from ten studies), one in adolescence (16–
18  years; n = 2906 from six studies), and none in adult-
hood (30–45 years; n = 1616 from three studies).
Although it seems that cord blood DNA methyla-
tion markers of birthweight do not persist at later ages, 
the associations observed at birth are extensive and it is 
important to confirm their persistence or variations over 
time. Also, DNA methylation profiles are tissue specific, 
and it would be optimal to analyse the DNA profile linked 
to birthweight in different tissues. Most tissues are not 
accessible with non-invasive methods, and blood is typi-
cally used as a surrogate, with the assumption that, being 
a universal body fluid, it may capture epigenetic changes 
of target tissues [19]. However, blood samples collection 
may be difficult in large population studies, as parents 
may be less prone to expose their children, and especially 
infants, to vein puncture for blood donation. Saliva and 
nasal brushes are easily accessible tissues, but to date 
they have been much less studied [20, 21]. Replication in 
saliva of blood epigenetic signatures of exposures and/or 
outcomes and identification of saliva-specific methyla-
tion markers could make saliva an optimal candidate for 
studies in infants and children. Thanks to its non-invasive 
collection method, it would allow obtaining repeated 
samples in short time periods, which is necessary req-
uisite for monitoring changes in DNA methylation over 
time.
Our aim was to perform a look-up, in infant saliva sam-
ples, of birthweight-related DNA methylation variation 
identified in cord blood, and to conduct, to our knowl-
edge, the first saliva epigenome-wide association study 
(EWAS) of birthweight, to identify methylation markers 
that may be specific for saliva collected in infancy.
Methods
Study population
The data were derived from an epigenome-wide case–
control study on wheezing nested within the NIN-
FEA birth cohort [22]. The NINFEA study is an Italian 
web-based multi-purpose mother–child cohort, aimed 
at exploring the relationship between early-life expo-
sures and long-term health outcomes [23]. Members of 
the cohort are children born from approximately 7500 
pregnant women who between 2005 and 2016 volun-
teered to participate in the study, had Internet access, 
and had enough knowledge of Italian to complete web-
based questionnaires. The children are followed up with 
six questionnaires completed by their mothers 6 and 
18  months after delivery, and when they turn 4, 7, 10, 
and 13  years of age. When children were aged approxi-
mately 6 months, mothers were asked to donate their and 
their children’s saliva samples using a mailed sponge Ora-
gene™ DNA self‐collection kits (OG‐250; DNA Genotek, 
Inc, Ottawa, Ontario, Canada). Approximately half of the 
participating mothers donated their and their child saliva 
samples, which are stored in a biobank at −80 ºC.
The case–control study was designed as EWAS of 
early childhood wheezing, consisting of 72 cases with at 
least one episode of wheezing between 6 and 18 months 
of age, and 72 infants without wheezing matched to 
cases by sex, age, and seasonality/calendar year of 
saliva sampling. Cases and controls were selected from 
a subpopulation of singletons, residents in the City of 
Turin, Italy, and born to mothers who did not report 
having asthma active during pregnancy. The baseline 
NINFEA questionnaire, completed at any time during 
pregnancy, was used to derive information on mater-
nal and pregnancy factors, while child-related variables 
were collected at the first follow-up questionnaire com-
pleted approximately 6 months after delivery. Although 
information on children ethnic background was not 
available in the NINFEA cohort, almost the entire study 
population has both parents born in Italy, and only few 
study children have one of the parents born in other 
European countries. Therefore, the ethnic background 
of the children included in the study is, if not entirely, 
largely European. In this study, we used the following 
variables: maternal age at delivery (years), maternal 
education (low = no education, primary or secondary 
school vs. high = university degree or higher), parity 
(nulliparous vs. at least one previous pregnancy > 22 
gestational weeks), maternal pre-pregnancy body 
mass index (BMI; kg/m2), sex, gestational age at birth 
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(weeks), birthweight (grams), small for gestational 
age (yes vs. no), age at saliva sampling (continuous in 
months) (see Table 1 for detail).
The Illumina  Infinium ® HumanMethylation450 
BeadChip (Illumina,Inc, San Diego, CA, USA) was 
employed to evaluate DNA methylation status of over 
485,000 probes in saliva samples. Details on pre‐pro-
cessing of samples and data quality control can be 
found in the Additional File 1 (Methods, DNA meth-
ylation measurement, data pre-processing, and quality 
control). Quality controls and probes filtering led to the 
exclusion of three samples and 63,218 probes, leading 
to a total of 141 saliva samples and 421,782 probes for 
analyses.
The NINFEA study was approved by Ethical Commit-
tee of the San Giovanni Battista and CTO/CRF/Maria 
Adelaide Hospital of Turin, and all participating moth-
ers gave informed consent at enrolment and at saliva 
donation.
Statistical analyses
For all the analyses, we pooled together cases and con-
trols, leading to a total of 141 subjects. The analyses were, 
however, based on 135 subjects, as 6 (4.3%) infants had 
missing values in at least one of the variables included in 
multivariable models. Methylation levels were analysed 
as β-values (ratio of methylated probe intensity to over-
all intensity, representing 0 to 100% methylation at each 
probe). Although, for normality assumption, log 2-trans-
formed β-values (M-values) may perform better when 
DNA methylation is used as an outcome, the interpreta-
tion of coefficients may be less intuitive. We, therefore, 
used β-values for more intuitive biological interpretation 
and easier comparability with other studies, in particular 
with the PACE birthweight EWAS. All the analyses were 
performed using R statistical computing software (ver-
sion 3.6.0) and RStudio (version 1.2.1335) [24].
Look‑up of PACE findings in infant saliva
Out of the 914 birthweight-associated CpGs identified by 
the PACE Consortium, 891 (97.5%) were available in the 
NINFEA study after quality checks and probes filtering. 
We used the same confounding variables of the PACE 
analysis, but, differently than in the PACE study, we used 
birthweight as the exposure and DNA methylation vari-
ation as the outcome to meet the biological temporality 
from birth to infancy. Both birthweight and DNA meth-
ylation were modeled as continuous variables. We used 
robust linear regression models adjusted for maternal 
age at delivery, maternal education, parity, maternal pre-
pregnancy BMI, child sex, gestational age at birth, age 
at saliva sampling, batch, and case–control status of the 
original nested case–control study (wheezing between 
6 and 18  months of age). Using vcovHC function in the 
sandwich R package [25], we calculated heteroscedastic-
ity-consistent standard errors.
Although maternal smoking during pregnancy affects 
both birthweight [26] and offspring DNA methylation 
[27], we did not adjust for smoking, as it was rather infre-
quent in our study sample (2% prevalence). In order to 
account for residual technical variability and for cell-type 
heterogeneity, we performed surrogate variables analysis 
(sva) [28] and estimated 7 surrogate variables that were 
also included as covariates in the model. Cell composi-
tion was additionally estimated using the reference-based 
projections for saliva proposed by Zheng [29], and given 
a high correlation between the epithelial tissue compo-
nent estimate and the first sva component (rho = 0.99), 
we only used the 7 estimated surrogate variables in the 
analyses. p-Values adjusted for multiple comparisons 
were calculated using the Bonferroni correction and 
the Benjamini and Hochberg false discovery rate (FDR), 
Table 1 Descriptive table for the NINFEA population under 
study (N = 141)
a BMI: body mass index (Kg/m2)
b Based on the 10th percentile of the WHO growth reference charts
Characteristics N or mean % or SD
Maternal pre-pregnancy  BMIa 22 3.0
Missing values 1 –
Maternal age at delivery (years) 35 4.1
Maternal education
 Low/medium (no university degree) 38 27%
 High (university degree or higher) 102 72%
 Missing values 1 1%
Parity
 First born 45 32%
 Non first born 92 65%
 Missing values 4 3%
Gestational duration (weeks)
 < 37 weeks 7 5%
 37+ weeks 134 95%
Child sex
 Female 61 43%
 Male 80 57%
Birthweight (grams) 3242 447.1
 Low (< 2500 g) 5 3.5%
 Medium (2500–4000 g) 128 90.8%
 High (> 4000 g) 8 5.7%
Small-for-gestational-ageb
 Yes 22 16%
 No 119 84%
Age at saliva sampling (months) 10.78 2.2
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while histograms and quantile–quantile (QQ) plots were 
used to graphically compare the observed distribution of 
p-values versus the expected uniform distribution under 
the null hypothesis. Given that the direction of the asso-
ciation was determined by the PACE study, we also calcu-
lated one sided p-values for each CpG. It has been shown 
that CpGs associated with a certain trait tend to be highly 
correlated and that this correlation affects standard pro-
cedures for multiple testing, such as Bonferroni and Ben-
jamini and Hochberg corrections. In the NINFEA saliva 
samples, the correlation between the 891 CpGs identi-
fied in the PACE EWAS was 0.48, which is indeed much 
higher than the reported saliva genome-wide mean cor-
relation of 0.12 [30]. We, therefore, reported the permu-
tation p-values that take into account the distribution of 
p-values under the null hypothesis and are suggested as a 
gold standard for the settings where the underlying cor-
relation between CpGs is high.
Epigenome‑wide association analyses
Two epigenome-wide association analyses were con-
ducted, first with birthweight as a continuous exposure 
variable and, second, with small for gestational age (SGA) 
as a binary exposure variable. The latter was defined as 
the lowest  10th percentile of the World Health Organiza-
tion birthweight for sex and gestational age charts [31], 
with the remaining population above the 10th percentile 
as the reference group. As in our study population only 7 
children (5%) were classified as large for gestational age 
(based on the  90th percentile), we had no power to ana-
lyse this trait separately and opted for a more conserva-
tive approach by including them in the reference group. 
In both EWAS analyses, we used robust linear regression 
models adjusted for sex, age at saliva sampling, gesta-
tional age, maternal age, parity, maternal pre-pregnancy 
BMI, maternal education, batch, estimated surrogate 
variables, and case–control status of the original nested 
case–control study. p-Values adjusted for multiple com-
parisons were calculated using the Benjamini and Hoch-
berg false discovery rate (FDR), and Volcano plots were 
used to visually present the results. In the EWAS of SGA, 
as a sensitivity analysis we provisionally excluded chil-
dren born pre-term (< 37 gestational weeks at birth).
To assess whether the age at saliva sampling could have 
influenced the findings on the top CpG sites identified in 
the EWAS analyses, we tested the associations of the age 
at saliva sampling as a continuous variable (in months) 
with the methylation levels in the top CpG sites using the 
robust linear regression models adjusted for sex, batch 
and cell type composition estimated with the reference-
based projections for saliva proposed by Zheng [29].
Finally, we performed a look-up of the saliva top find-
ings in the PACE summary results, publicly available via 
Zenodo: https:// zenodo. org/ record/ 22222 87#. YDOhC 
tWSmUk.
CpGs annotation and functional analysis
Gene Ontology (GO) and Kyoto Encyclopedia of gene 
and Genomes (KEGG) enrichment analyses were carried 
out to identify possible functional pathways in the saliva 
birthweight-associated CpGs set.
In order to compare previously reported associations 
of epigenome-wide birthweight-associated CpGs and 
our own results, we searched for findings reported in the 
EWAS Catalog (http:// www. ewasc atalog. org; accessed on 
12 February 2021) and EWAS Atlas (https:// bigd. big. ac. 
cn/ ewas/ tools; accessed on 12 February 2021), looking 
for both CpG and gene level match.
After this first step based on the overlap between our 
results and those of other EWAS on the same trait, we 
further accessed EWAS Atlas to examine whether CpGs 
identified in our study were previously associated with 
traits other than birthweight.
We also looked in the GWAS Catalog for traits asso-
ciated with specific single-nucleotide polymorphisms 
(SNPS) on genes on which these CpGs mapped.
Results
Table 1 shows the characteristics of the study population. 
The mean maternal age was 35 years; 72% of the mothers 
had a high educational level. The mean age at saliva sam-
pling was 10.8  months (median 10.4, range 7–17). The 
mean birthweight was 3242  g, 5% of the children were 
born pre-term and 15.6% of children were born small for 
gestational age, respectively).
Look‑up of PACE findings in infant saliva
Of the 891 CpG sites associated with birthweight in the 
PACE study, 52 (5.8%) had a one sided p-value < 0.05 in 
our study (Fig.  1, Table  2). However, none of the CpGs 
survived the Bonferroni correction (p < 5.61 ×  10−5) or 
had a FDR < 0.05 (Table  2, Additional file  2: Table  S1). 
There was a 47% concordance in the direction of the 
coefficients between the PACE and our study (binomial 
sign test p-value = 0.11, 95% confidence intervals (CIs) 
0.44; 0.51). When we used the permutation test to take 
into account strong mean pairwise correlation between 
the DNA methylation values of the 891 CpG sites, the 
minimum permutation p-value was 0.56.
EWAS for continuous birthweight
Out of the 421,782 probes analysed, 8.9% (N = 37,365) 
were associated with birthweight with a nominal 
p-value < 0.05. After correction for multiple testing, 44 
CpG sites had a FDR < 0.05 (Table  3 and Fig.  2a). Their 
coefficient estimates ranged from – 0.31 to 0.57, which 
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corresponds to a methylation increase of 0.57% with a 
100 gr increase in birthweight. The largest effect was 
observed for cg02727104 located 13 kb down SOHLH2.
None of the 44 saliva birthweight-associated CpGs 
overlapped with the birthweight related CpGs identified 
in cord blood in the PACE study under the Bonferroni 
threshold. When considering a nominal p-value < 0.10 in 
the PACE study (N = 78,489 CpGs), there was an over-
lap in 6 CpG sites, but only one with the same direction 
of the effect (cg22896429) (Additional file  3: Table  S1). 
At gene level, there was an overlap in 12 genes identi-
fied in PACE under the FDR-corrected p-value thresh-
old (with at least one CpG with the same direction of the 
effect). The average absolute pairwise Pearson’s correla-
tion coefficient between the β-values of the identified 44 
CpGs was 0.23, which is higher than the mean pairwise 
genome-wide correlation coefficient in the NINFEA 
saliva samples but lower than the mean pairwise cor-
relation coefficient between 891 CpGs identified by the 
PACE Consortium [30].
EWAS for small for gestational age
We found 44 CpGs associated with SGA at a FDR of 
less than 0.05 (Table  4 and Fig.  2b). The largest coef-
ficient showed a 4.1% difference in methylation when 
comparing small with non-small for gestational age 
(cg12322146, located 125  kb down RBMS3); the larg-
est negative association was -2.3% (cg03066788, 
located at PNOC). Only one CpG (cg18072629, located 
at GATA3)  overlapped with the 44 CpGs found to be 
Fig. 1 Histogram and qq-plot of the two-sided p-values from the look-up of PACE cord blood findings in infant saliva
Table 2 Results from the look-up of the PACE cord blood findings in the NINFEA saliva samples
Results N (%)
Number of CpGs tested 891
Number of CpGs with two sided p-value < 0.05 81 (9.1%)
Number of CpGs with one sided p-value < 0.05 52 (5.8%)
Number of CpGs concordant in the direction of the effect between the PACE and NINFEA study 421 (47.3%)
Family-wise error rate (Bonferroni-corrected p-values) < 5.61 ×  10−5 0
Number of CpGs with permutation-corrected p-value < 0.05 0
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Table 3 Top 44 CpGs from EWAS study with Benjamini and Hochberg false discovery rate (FDR)‐adjusted p‐values < 0.05. The effect is 
estimate as the difference in % of methylation per 100 g in birthweight difference. In bold the CpG with the strongest effect
CpG Chromosome Gene allocation or nearest gene Effect estimate Standard error Nominal p-value FDR 
corrected 
p-value
cg03045325 11 MACROD1 − 0.266 4.89E−06 3.53E−07 0.046
cg19854704 10 95 kb down ENSG00000286295 0.165 3.03E−06 3.56E−07 0.046
cg07728793 2 RAMP1 − 0.155 2.90E−06 4.91E−07 0.046
cg18072629 10 GATA3 − 0.112 2.13E−06 7.03E−07 0.046
cg05005073 1 10 kb up NDUFS5 0.233 4.44E−06 8.01E−07 0.046
cg09516627 2 CENPO 0.155 2.97E−06 8.07E−07 0.046
cg02727104 13 13 kb down SOHLH2 0.569 1.09E−05 8.7E−07 0.046
cg26725813 15 ZNF770 − 0.136 2.63E−06 9.99E−07 0.046
cg05931551 1 TUT4 − 0.290 5.61E−06 1.08E−06 0.046
cg26392737 8 DMTN 0.268 5.21E−06 1.21E−06 0.046
cg04512603 7 ZNF273 − 0.072 1.39E−06 1.24E−06 0.046
cg23218354 1 50 kb down ACTRT2 0.565 1.10E−05 1.4E−06 0.046
cg09855212 11 SYTL2 0.169 3.32E−06 1.43E−06 0.046
cg04305601 16 ZNF423 − 0.215 4.25E−06 1.72E−06 0.046
cg13590166 10 70 kb down WAC − 0.211 4.18E−06 1.86E−06 0.046
cg01807862 5 MCIDAS − 0.159 3.16E−06 1.91E−06 0.046
cg14781041 1 SIPA1L2 0.105 2.10E−06 2.25E−06 0.046
cg15915658 11 30 kb down SCYL1 0.307 6.14E−06 2.3E−06 0.046
cg03466415 2 SCN9A 0.142 2.85E−06 2.32E−06 0.046
cg22453818 5 LHFPL2 0.254 5.09E−06 2.43E−06 0.046
cg07175848 16 SNTB2 − 0.204 4.11E−06 2.7E−06 0.046
cg18971416 10 THNSL1 0.129 2.60E−06 2.72E−06 0.046
cg18152712 6 E2F3 0.115 2.32 E−06 2.76E−06 0.046
cg08060902 19 ZNF709 − 0.151 3.05 E−06 2.8E−06 0.046
cg04963607 7 PRKAR1B − 0.135 2.72 E−06 2.87E−06 0.046
cg00483825 10 CFAP46 − 0.157 3.19 E−06 2.99E−06 0.046
cg18417562 5 CTNNA1 − 0.198 4.03 E−06 3.07E−06 0.046
cg09361653 17 RPTOR − 0.192 3.91 E−06 3.18E−06 0.046
cg22896429 6 MTHFD1L 0.165 3.37 E−06 3.33E−06 0.046
cg19794939 11 LGR4 0.101 2.07 E−06 3.48E−06 0.046
cg03113121 19 FOXA3 0.178 3.63 E−06 3.49E−06 0.046
cg23114964 1 HIVEP3 − 0.229 4.69 E−06 3.67E−06 0.046
cg06527318 1 MIR4425 − 0.313 6.42 E−06 3.77E−06 0.046
cg20100049 11 KMT5B − 0.204 4.18 E−06 3.84E−06 0.046
cg20515787 11 SART1 0.108 2.21 E−06 3.91E−06 0.046
cg13680864 10 STAM 0.235 4.82 E−06 3.96E−06 0.046
cg23096644 7 SGCE 0.167 3.44 E−06 4.37E−06 0.047
cg03722643 2 GPR45 − 0.044 9.07 E−07 4.43E−06 0.047
cg19857227 14 ENSG00000240914 − 0.215 4.45 E−06 4.49E−06 0.047
cg08707988 6 41 kb up LOC100294145 − 0.258 5.33 E−06 4.51E−06 0.047
cg09749788 8 MCPH1-AS1 0.229 4.76 E−06 4.7E−06 0.047
cg06655187 17 ZNHIT3 0.125 2.59 E−06 4.79E−06 0.047
cg10800369 12 LMO3 0.327 6.80 E−06 4.91E−06 0.047
cg24864887 15 800b down ISL2 0.347 7.20 E−06 4.92E−06 0.047
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associated with continuous birthweight in our sam-
ple. None of the 44 saliva SGA-associated CpGs over-
lapped with the 914 CpGs associated with continuous 
birthweight (at Bonferroni threshold), or with the 4 
CpGs associated with low birthweight (< 2500 g) in the 
PACE study conducted on cord blood samples. When 
considering a nominal p-value < 0.10 in the PACE 
study, there was an overlap in 7 CpG sites, but only two 
with consistent direction of the effect (cg06234201, 
cg15847996). (Additional file  3: Table  S1). At gene 
level, there was an overlap in 9 genes identified in 
PACE under the FDR-corrected p-value threshold 
(with at least one CpG with consistent direction of the 
effect).
Findings were practically unchanged when we 
excluded preterm infants from the EWAS analysis 
(data not shown). We found no association between 
age at saliva sampling and methylation status for any of 
the top CpGs associated with continuous birthweight 
or with SGA in our two EWAS analyses.
Out of 44 CpG sites associated with continuous 
birthweight in our EWAS, 28 (64%) showed a nominal 
p-value < 0.05 in the EWAS for SGA; all with a direc-
tion of the effect that was consistent with the results 
for birthweight. Likewise, 26 (59%) out of 44 SGA-
related CpGs reveal nominal p-value < 0.05 in the 
EWAS of continuous birthweight, with a consistent 
direction of the effect.
CpGs Annotation and functional analysis
None of the two sets of CpGs identified in our study, the 
44 birthweight-associated CpGs and the 44 SGA-asso-
ciated CpGs, showed functional enrichment of GO or 
KEGG terms.
Also, there was no overlap between the CpGs identified 
in our EWAS on continuous birthweight and 995 birth-
weight-related CpGs reported in 4 cord-blood and sub-
cutaneous adipose tissue studies from the EWAS Atlas 
data [32–34], including the PACE study [18]. In EWAS 
Atlas and EWAS Catalog, DNA methylation in six out of 
87 genes was previously associated with birthweight, all 
in the PACE study at Bonferroni threshold. In addition, 
some genetic variants in these six genes have been pre-
viously associated with obesity [35], adult BMI [36–42], 
BMI-adjusted waist-hip ratio [37, 38, 41, 43, 44], high-
density lipoprotein cholesterol measurement [45–47], 
and visceral adipose tissue measurement [48].
In the EWAS Catalog, there were 34 CpGs associated 
with birthweight in four studies using DNA methyla-
tion in cord blood [49–52], but none of these overlapped 
with the 87 CpGs found to be associated with birth-
weight or SGA in our study. In the EWAS Atlas, DNA 
methylation in 29 out of these 87 CpGs was associated 
Fig. 2 Volcano plot of the two EWAS. a Volcano plot showing p-values and direction of associations of DNA methylation variation with continuous 
birthweight. 44 FDR < 0.05 highlighted in red. The blue line is Bonferroni threshold, the red line nominal p-value threshold (p < 0.05). The X-axis 
represents the % difference in methylation per 100 g in birthweight difference, and the Y-axis represents the − log10(p-value). b Volcano plot 
showing p-values and direction of associations of DNA methylation variation with AGA vs. SGA. 44 FDR < 0.05 highlighted in red. The blue line is 
Bonferroni threshold, the red line nominal p-value threshold (p < 0.05).The X-axis represents the % difference in methylation per AGA vs. SGA, and 
the Y-axis represents the − log10(p-value). In green the CpG that overlap with 44 CpGs on continuous birthweight
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Table 4 44 CpGs associated with AGA vs. SGA when treats birthweight as categorical variable. The coefficient estimates are the 
difference in % of methylation per AGA vs. SGA. In bold the CpG with the strongest effect
CpG Chromosome Gene allocation or nearest gene Effect estimate Standard error Nominal p-value FDR 
corrected 
p-value
cg26168577 17 MRC2 1.374 2.17E−03 5.36E−09 0.002
cg03066788 8 PNOC − 2.371 3.92E−03 2.07E−08 0.004
cg26615232 1 USH2A − 1.304 2.31E−03 1.3E−07 0.017
cg12055114 19 LMNB2 0.898 1.62E−03 2.18E−07 0.017
cg04873627 4 TBC1D19 1.771 3.20E−03 2.3E−07 0.017
cg15225594 5 20 kb down ERCC8 2.016 3.68E−03 2.76E−07 0.017
cg01286950 2 AFF3 − 0.747 1.37E−03 3.4E−07 0.017
cg18072629 10 GATA3-AS1 0.715 1.32E−03 3.62E−07 0.017
cg13984701 9 COL5A1 4.051 7.49E−03 3.88E−07 0.017
cg26332310 1 BARHL2 − 1.867 3.47E−03 4.39E−07 0.017
cg24391471 3 ZDHHC3 − 0.829 1.55E−03 4.84E−07 0.017
cg02547025 2 LBH − 0.517 9.69E−03 5.26E−07 0.017
cg23508813 3 2.5 kb down LOC100507274 2.372 4.45E−03 5.33E−07 0.017
cg26589351 17 SPOP − 1.370 2.58E−03 5.97E−07 0.018
cg06234201 16 DUS2 2.202 4.16E−03 6.49E−07 0.018
cg23954819 12 BRI3BP − 2.136 4.06E−03 7.26E−07 0.019
cg19445996 17 RAB37 − 0.744 1.42E−03 7.85E−07 0.019
cg02980127 14 14,5 kb down ENSG00000258736.1 1.402 2.70E−03 9.4E−07 0.022
cg22869025 20 ACSS1 0.629 1.22E−03 1.14E−06 0.025
cg19403534 10 PRLHR 1.688 3.28E−03 1.22E−06 0.025
cg12322146 3 125 kb down RBMS3 4.106 8.01E−03 1.31E−06 0.025
cg06458489 5 150 kb down SNORA63 − 0.999 1.95E−03 1.38E−06 0.025
cg00383136 6 HLA-DRA 1.370 2.68E−03 1.39E−06 0.025
cg16899265 18 GRP − 1.257 2.47E−03 1.59E−06 0.027
cg15847996 10 INPP5A 2.390 4.71E−03 1.61E−06 0.027
cg08715720 5 PPP2R2B 0.780 1.55E−03 1.83E−06 0.030
cg20388707 2 NGEF 1.510 3.03E−03 2.31E−06 0.036
cg01504555 16 SYCE1L − 0.766 1.54E−03 2.4E−06 0.036
cg07965823 14 ISM2 − 0.820 1.65E−03 2.64E−06 0.036
cg20244295 15 ZNF710 1.049 2.12E−03 2.65E−06 0.036
cg09311778 17 2 kb down KAT7 − 0.795 1.61E−03 2.78E−06 0.036
cg05754929 16 GSE1 − 1.993 4.03E−03 2.81E−06 0.036
cg18246134 3 LINC02877 − 0.767 1.55E−03 2.85E−06 0.036
cg21688288 21 PDE9A 1.994 4.05E−03 3.08E−06 0.038
cg22159939 1 30 kb down CENPF − 1.137 2.32E−03 3.49E−06 0.042
cg25271404 15 GOLGA8B − 0.617 1.26E−03 3.62E−06 0.042
cg24745895 7 5 kb up AKR1D1 0.669 1.38E−03 4.01E−06 0.044
cg17836487 2 TMEM131 − 1.328 2.73E−03 4.07E−06 0.044
cg24113784 17 MIEF2 1.050 2.16E−03 4.08E−06 0.044
cg00701706 17 OTOP3 − 1.747 3.62E−03 4.57E−06 0.048
cg24663455 10 50,5 kb down MGMT − 1.615 3.35E−03 4.73E−06 0.048
cg08935613 11 HYLS1 − 0.720 1.50E−03 4.83E−06 0.048
cg22213242 11 CD248 1.191 2.48E−03 4.91E−06 0.048
cg24420742 12 NAV3 1.994 4.15E−03 4.96E−06 0.048
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with different traits (Additional file  1: Tables S1 and 
S2). DNA methylation variation at eleven of them has 
been previously associated with insulin resistance [53] 
(cg03045325), colorectal cancer [54] (cg02727104, 
cg26332310, cg12322146), obesity [55] (cg03066788), 
bariatric surgery [56] (cg20515787, cg02547025), mor-
tality [57] (cg06234201), gestational diabetes mellitus 
[58] (cg00383136), amount of visceral adipose tissue [59] 
(cg20388707), and gestational age [34] (cg00701706).
Some of the birthweight- and SGA-associated CpGs 
in our study map in genes which variants were associ-
ated with the following traits: birthweight (USH2A), BMI 
(CENPO, E2F3, RPTOR, SNTB2, PNOC, LGR4), body fat 
distribution (CENPO), waist-hip ratio (SYTL2, ZNF423, 
FOXA3, LMNB2, COL5A1,LGR4), BMI-adjusted waist 
hip ratio (ZNF423, AFF3), cardiovascular disease 
(SIPA1L2, FOXA3, RAB37, INPP5A), subcutaneous or 
visceral adipose tissue measurement (FOXA3, RPTOR), 
gestational age (CFAP46, INPP5A), lipoprotein choles-
terol measurement (DMTN, SNTB2), total cholesterol 
measurement (E2F3, DMTN), type I diabetes nephropa-
thy (AFF3), type II diabetes mellitus (RAMP1, SYCE1L, 
ZNF710). Finally at gene level, out of saliva 87 CpGs 
associated with birthweight and SGA, DNA methylation 
at 14 genes was associated with birthweight, 22 with BMI 
and 32 with obesity in previous studies found in EWAS 
Atlas and EWAS Catalog. Full results are shown in Addi-
tional file 1: Tables S1 and S2.
Discussion
In this study, we investigated the association between 
birthweight and methylation patterns in saliva samples 
taken at around 10 months of age. The cord blood meth-
ylation signatures of birthweight, found by a large study 
of the PACE Consortium, were not confirmed in infant 
saliva.
We identified 87 infant saliva-specific signatures of 
birthweight or SGA, of which two overlap with PACE 
results at gene level with the same direction of effect 
(MACROD1 and RPTOR). Interestingly, single-nucle-
otide polymorphisms in these genes have been previ-
ously associated with obesity, adult BMI, BMI-adjusted 
waist-hip ratio, high-density lipoprotein cholesterol and 
visceral adipose tissue levels. Moreover, expanding the 
look-up in the full PACE results, 13 CpGs find corre-
spondence with a nominal p-value < 0.10 but only 3 have 
the same direction of the effect, namely cg22896429, 
cg06234201, cg15847996.
DNA methylation variation at some of the 87 loci 
identified in our study has been previously associated 
with multiple traits, such as insulin resistance, colorec-
tal cancer, obesity, and gestational diabetes mellitus. 
Moreover, the SGA-associated locus cg26615232 maps 
within USH2A, which variant has been associated with 
birthweight in a study [63] that performed GWAS meta-
analyses of fetal genetic variants in 321,223 individuals of 
European ancestry.
It has been repeatedly shown that DNA methylation at 
many sites is not temporally stable and that each tissue 
has its unique epigenetic landscape that likely reflects its 
specific function and response to environmental expo-
sures [21, 64]. For example, a cross-sectional study on 
1019 infants [65] compared the associations between 
preterm birth and genome-wide DNA methylation pro-
files using both cord tissue and cord blood samples. The 
results highlighted differences between the two tissues 
in DNA methylation variation associated with preterm 
birth, with only a minority of overlapping CpGs. In DNA 
from cord tissue, DNA methylation analysis showed 
enrichment of differentially methylated regions in genes 
involved in molecular pathways related to fetal growth 
and development (i.e. Wnt signaling, bone remodeling, 
and extracellular matrix organization), while in cord 
blood immune response pathways (i.e. regulation of T 
cell differentiation, inositol lipid-mediated signaling, and 
regulation of RNA stability) were enriched. Therefore, it 
is reasonable to speculate that saliva and blood, which 
have different functions, include different cell types and 
have different embryonic origin, and different mecha-
nisms of exposure and responses to environmental fac-
tors do not share the same DNA methylation response to 
fetal growth, birthweight, and their risk factors. Although 
our results suggest different cord blood and saliva meth-
ylation patterns related to birthweight, we cannot exclude 
that the relatively small sample size of our study contrib-
uted to the lack of overlap with the PACE results, due to a 
reduced power to detect small effects.
In addition to the tissue specificity of DNA methyla-
tion, there are also age-related changes (birth vs. infancy) 
that could explain differences between our and the PACE 
Consortium findings.
In most tissues, DNA methylation may also vary sub-
stantially with time, especially during periods of life 
associated with high plasticity and fast development. 
Consistently, the PACE study found that differential 
methylation associated with birthweight in neonates per-
sisted only minimally across childhood and disappeared 
by adulthood [18].
This result is consistent with another longitudinal study 
in which birthweight- and gestational age-related DNA 
methylation changes were investigated in cord blood and 
peripheral blood at ages 7 and 17 in more than 900 chil-
dren [66]. Across the majority of CpG sites that showed 
differential methylation in cord blood, a pattern of fast 
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evolution was observed during early childhood that stops 
with adolescence, providing evidence for the lack of per-
sistence of early life methylation differences.
This is evident also in two studies that analysed infant 
saliva samples. A longitudinal study with repeated saliva 
samples collected at birth and at 1  year of age from 50 
preterm and 40 infants born at term showed that DNA 
methylation at the differentially methylated region 
(DMR) of IGF2 and FKBP5 at birth was lower in preterm 
infants compared with term infants, but these differences 
did not persist at 1 year of age [67]. Also, another study 
on 214 infant saliva samples (62 collected at 6 weeks of 
age, 30 collected at 52  weeks of age and 61 collected at 
both ages) showed an age-dependent variation of DNA 
methylation, with a clear difference between saliva DNA 
methylation at 6 and 52 weeks of age [68].
In our study, we could not distinguish between the 
tissue- and the time-related differences in DNA meth-
ylation of birthweight-associated CpG sites, as we had 
no repeated saliva samples or blood samples collected 
simultaneously with saliva. It would be interesting in 
future studies with repeat samples and also with different 
tissues, to investigate whether the differences between 
our and PACE findings are due to the time- and tissue- 
dependent DNA methylation changes, as reported by 
previous studies both for birthweight and gestational age. 
Even though the age at saliva sampling varied between 
7 and 17  months in our study, age was not associated 
with DNA methylation variation in any of the CpG sites 
associated with continuous birthweight and SGA, sug-
gesting that the observed associations are unlikely influ-
enced by the different age of saliva collection. It should 
be, however, noted that the age range of our population 
was rather narrow (7–17 months), so we cannot exclude 
that age could influence DNA methylation in these CpGs 
when considered across childhood/adolescence.
We supplemented the analysis of birthweight with the 
analysis on SGA and found different CpG sites associated 
with the two exposures, with only 1 overlapping CpG 
when considering FDR-corrected p-values. Although 
this is in line with the PACE analyses, where the 4 CpGs 
associated with low birthweight (< 2500 g) did not over-
lap with the 914 associated with continuous birthweight, 
approximately 60% of CpGs identified in our two EWAS 
overlapped at the nominal p-value of 0.05, with seem-
ingly the same direction.
The main strength of our study was the possibility to 
analyse DNA methylation in saliva samples, which are 
easy to collect at any age in childhood and are, there-
fore, good candidates for future large DNA methyla-
tion studies. Moreover, while it is probably unfeasible 
to collect repeated blood samples over relatively short 
time periods, and especially in the context of large 
population studies based on children, it is possible to 
use saliva to monitor changes in DNA methylation over 
time. As salivary DNA methylation is poorly studied, 
especially in newborns and infants, it would be impor-
tant to understand if, and for which specific traits and 
exposures, salivary and blood DNA methylation can 
be used interchangeably, and when they clearly show 
distinct methylation signatures. Previous DNA meth-
ylation studies using saliva samples focused on neu-
robehavioural conditions [69–71], respiratory traits 
[22], and cancer research [72], but to our knowledge 
the associations between birthweight and saliva DNA 
methylation has not been studied so far.
Although the small sample size of our study, espe-
cially in comparison with the PACE study, may have 
had an impact on EWAS analyses, after an FDR-cor-
rection, we identified some novel CpGs associated with 
birthweight, which are likely to be saliva-specific birth-
weight signatures. These findings need replication in 
independent saliva EWAS, and we cannot exclude that 
additional saliva DNA methylation variations related to 
offspring birthweight may be identified by larger stud-
ies. We argue that the sample size had less impact on 
our look-up analysis of PACE findings in saliva, as the 
number of tests performed in the look-up analysis was 
much lower than the number of tests of the two EWAS.
Our study population was not selected at random 
from the entire NINFEA cohort, but on the presence/
absence of infant wheezing between 6 and 18  months 
of age, which was a selection factor for the original 
case–control study. As SGA is a well-known risk fac-
tors for wheezing [73, 74], this selection led to a rela-
tively high prevalence of SGA infants (15.6%; 21% in 
wheezing cases and 10% in controls). To account for 
this selection, all the analyses were adjusted also for 
infant wheezing. Moreover, SGA definition is based on 
an arbitrary population-based reference cut-off, while, 
biologically, size for gestational age can be considered 
as a continuous trait. Therefore, the high prevalence of 
SGA in our study population allowed us to capture the 
lowest quintile of the size for gestational age distribu-
tion, providing more power for EWAS.
Finally, it should be noted that the prevalence of 
maternal smoking during pregnancy was rather low in 
our study population (2% compared with 7.7% of mater-
nal smoking during pregnancy and with 14% of mater-
nal smoking just before pregnancy in the entire cohort) 
[4]. In addition to random variation, the selection pro-
cess may have played a role also in this case, although 
with an unexpected direction. Therefore, our findings 
are less generalizable to the population of women who 
smoke during pregnancy, but remain applicable to all 
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non-smoking women and those who stopped smok-
ing before pregnancy, which represent the majority of 
pregnant women.
Conclusion
In conclusion, our study provides an indication of the 
birthweight and small for gestational age epigenetic sali-
vary signatures in children around 10 months of age and 
suggests that DNA methylation signatures of birthweight 
likely differ between cord blood and infant saliva. Further 
insights are needed to understand whether these differ-
ences are due to biological differences between the two 
tissues or could be attributed to age-related DNA meth-
ylation changes.
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